BJDX (Bluejay Diagnostics, Inc. Common Stock) Stock Analysis - SEC Filings

Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.79 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BJDX SEC filings?

Rallies organizes BJDX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BJDX Key Metrics

Key financial metrics for BJDX
MetricValue
Price$1.79
Market Cap$1.78M
P/E Ratio-0.11
EPS$-15.25
Dividend Yield0.00%
52-Week High$49.80
52-Week Low$1.62
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-6.85M
Gross Margin0.00%

Latest BJDX News

Recent BJDX Insider Trades

  • Wurth Douglas Clark bought 12.50K (~$25.00K) on Mar 14, 2026.
  • Dey Indranil bought 12.50K (~$25.00K) on Mar 14, 2026.
  • CHASE DONALD R bought 12.50K (~$25.00K) on Mar 14, 2026.

BJDX Analyst Consensus

BJDX analyst coverage data. Average price target: $0.00.

Common questions about BJDX

Where can I find BJDX SEC filings?
Rallies organizes BJDX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BJDX 10-K and 10-Q filings?
Rallies organizes BJDX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BJDX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.
BJDX

BJDX